HomeCompareELVAY vs MRK

ELVAY vs MRK: Dividend Comparison 2026

ELVAY yields 42.97% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ELVAY wins by $215.4K in total portfolio value
10 years
ELVAY
ELVAY
● Live price
42.97%
Share price
$1.16
Annual div
$0.50
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$272.2K
Annual income
$48,798.02
Full ELVAY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ELVAY vs MRK

📍 ELVAY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodELVAYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ELVAY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ELVAY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELVAY
Annual income on $10K today (after 15% tax)
$3,652.28/yr
After 10yr DRIP, annual income (after tax)
$41,478.32/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ELVAY beats the other by $33,149.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELVAY + MRK for your $10,000?

ELVAY: 50%MRK: 50%
100% MRK50/50100% ELVAY
Portfolio after 10yr
$164.5K
Annual income
$29,298.08/yr
Blended yield
17.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ELVAY
No analyst data
Altman Z
-116.1
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELVAY buys
0
MRK buys
0
No recent congressional trades found for ELVAY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricELVAYMRK
Forward yield42.97%2.76%
Annual dividend / share$0.50$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$272.2K$56.8K
Annual income after 10y$48,798.02$9,798.13
Total dividends collected$209.0K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ELVAY vs MRK ($10,000, DRIP)

YearELVAY PortfolioELVAY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$14,997$4,296.80$11,206$366.19+$3.8KELVAY
2$22,069$6,022.27$12,650$502.35+$9.4KELVAY
3$31,896$8,282.42$14,407$694.19+$17.5KELVAY
4$45,316$11,187.46$16,585$967.82+$28.7KELVAY
5$63,343$14,854.72$19,342$1,363.89+$44.0KELVAY
6$87,183$19,405.55$22,913$1,947.19+$64.3KELVAY
7$118,247$24,961.63$27,662$2,823.89+$90.6KELVAY
8$158,165$31,640.94$34,159$4,173.35+$124.0KELVAY
9$208,791$39,553.64$43,337$6,308.80+$165.5KELVAY
10$272,204$48,798.02$56,776$9,798.13+$215.4KELVAY

ELVAY vs MRK: Complete Analysis 2026

ELVAYStock

Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.

Full ELVAY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ELVAY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELVAY vs SCHDELVAY vs JEPIELVAY vs OELVAY vs KOELVAY vs MAINELVAY vs JNJELVAY vs ABBVELVAY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.